Rezolute Posts Narrower Loss In Q4; Expects Phase 3 Ersodetug Topline Data By 2026 End

Rezolute, Inc. (RZLT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Rezolute Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Business Update REDWOOD CITY, Calif., September 24, 2026 – Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage ultra-rare rare disease company focused on tr

Rezolute reported early results from its rare hypoglycemia (tumor hyperinsulinism) study of ersodetug. The company said 6 of 8 enrolled participants met the primary endpoint, achieving ≥50% reduction in intravenous glucose needs (GIR) during the 8-week pivotal phase and fully stopping IV glucose. One participant withdrew and died after hospice transition and was deemed a non-responder. Rezolute said safety remains favorable and no drug-related adverse events have been reported.

Rezolute Inc. reported positive interim Phase 3 upLIFT results for ersodetug in tumor-related hyperinsulinism. The trial enrolled 8 of 16 planned patients; 6 of the first 8 met the primary endpoint, with ≥50% reductions in IV glucose needs during the 8-week pivotal phase, and all six stopped IV glucose while on treatment. No drug-related adverse events were reported. Rezolute expects topline results in H2 2026.

Tamboran Resources Corp (TBN) filed an SEC Form 8-K — Results of Operations and Financial Condition. ` NYSE: TBN, ASX: TBN 4Q FY26 Result Presentation Mr. Todd Abbott – Chief Executive Officer September 25, 2026 The information in this presentation includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities A

Scholastic (SCHL) reported a wider Q1 FY27 net loss of $71.2M (vs. $71.1M YoY) on revenues of $216.8M, down 4% YoY. The company maintained its FY27 outlook, expecting 2-4% revenue growth and adjusted EBITDA of $135M-$145M. Shares dropped 11% overnight.

U.S. stock futures rise, but bond selloff pressures equities. The 10-year Treasury yield hits 5.2%, its highest since 2007, due to oil prices and Fed rate expectations. Costco reports Q4 earnings beating estimates, with EPS of $6.75 and revenue of $95.7B. Oil prices dip on U.S.-Iran talks over Hormuz Strait. Elon Musk plans to double Nvidia chips in Colossus 2 data center by year-end.